IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Linking altered gut microbiome to polycystic ovarian syndrome through immune mediated pathway
- Pathak V.A. , et al.
2. Exploring the mechanism of proteinuria reduction by hydroxychloroquine in IgA nephropathy using network pharmacology and molecular mocking
- Lu M. , et al.
3. Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets
- Lai X. , et al.
5. Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis
- Pirhoushiaran M. , et al.
6. A high-throughput RNA sequency of peripheral blood mononuclear cells reveals on inflammatory state in women with PCOS
- Heidarzadehpilehrood R. , et al.
7. A Cross-Sectional Exploratory Study of Rat Sarcoid (Ras) Activation in Women with and Without Polycystic Ovary Syndrome
- Niinuma S.A. , et al.
8. Silencing of long non-coding RNAs MIR22HG, LNCTAM34A, and TP53TG1 triggers cell survival/proliferation and inhibits apoptosis in women's breast cancer
- Al-Kateb A. , et al.
9. Dysregulated key long non-coding RNAs TP53TG1, RFPL1S, DLEU1, and HCG4 associated with epithelial-mesenchymal transition (EMT) in castration-resistant prostate cancer
- Mehrabi T. , et al.
10. CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis
- Luo X. , et al.
11. Polycystic Ovary Syndrome and Ferroptosis: Following Ariadne’s Thread
- Geronikolou S. , et al.
12. Upregulated long non-coding RNAs TMPO-AS1, DDX11-AS1, and POLE gene expression predict poor prognosis in head and neck squamous cell carcinoma (HNSCC)
- Mokhtarinejad M. , et al.
13. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS)
- Heidarzadehpilehrood R. , et al.